Please login to the form below

Not currently logged in
Email:
Password:

Unified Patent Court

This page shows the latest Unified Patent Court news and features for those working in and with pharma, biotech and healthcare.

Innovation and the pharma patent court

Innovation and the pharma patent court

Innovation and the pharma patent court. As the UK prepares to exit the European Union a unified patent system is still essential. ... However, participation in the UPC system includes accepting that the judgments of the European courts will prevail over

Latest news

  • Brexit: Bad for health, science and pharma Brexit: Bad for health, science and pharma

    A Leave vote would consequently seem to make it untenable for the EMA - which employs 885 people in the UK - as well as the soon-to-be-launched Unified Patent Court ... Its position is that EU membership offers the UK 'various advantages', pointing to

  • UK biopharma says Brexit would be UK biopharma says Brexit would be "bad for business"

    It has been suggested that in the event of Brexit the EMA and the soon-to-be-launched Unified Patent Court would be relocated from London, according to a report in

  • Opt in or opt out? Opt in or opt out?

    The Unitary Patent (UP) and Unified Patent Court (UPC) will fundamentally change the way patents are granted and enforced in Europe. ... There are many other aspects of the Unified Patent package that may influence the future thinking of life sciences

  • Politically acceptable - a unified patent for Europe Politically acceptable - a unified patent for Europe

    Politically acceptable - a unified patent for Europe. But will Europe’ s Unified Patent Court help or harm the pharma sector? ... The Unified Patent Court (UPC) is the result of an agreement between 27 European countries to create a single patent for

  • European pharma patent court deal sealed European pharma patent court deal sealed

    EU Member State ministers at the signing ceremony for the international agreement on a Unified Patent Court (Picture: The Council of the European Union). ... The agreement settles the details of the overarching Unified Patent Court, which will have a

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Brexit implications for UK pharma legislation Brexit implications for UK pharma legislation

    Without a withdrawal agreement, the UK’s participation in the European Patent and the Unified Patent Court, whose division dealing with life science cases is due to be housed in London,

  • Brexit: Implications for the pharma industry Brexit: Implications for the pharma industry

    Patents. In November 2016, the UK Government announced it would proceed with plans to ratify the Unitary Patent and Unified Patent Court (UPC) regime, with the UPC likely to operate from ... The current European Patent system will be unaffected by Brexit

  • Deal Watch June 2016 Deal Watch June 2016

    It is most likely that the Unitary Patent system and Unified Patent Court (UPC) Agreement will be delayed for years (Unitary Patents are intended to provide a cost-effective means of ... pan-EU patent protection without the need to validate each patent

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics